In the BioHarmony Drug Report Database
Rofecoxib
Vioxx (rofecoxib) is a small molecule pharmaceutical. Rofecoxib was first approved as Vioxx on 1999-05-20. It is used to treat dysmenorrhea and osteoarthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 2.
Trade Name
|
Vioxx |
|---|---|
Common Name
|
rofecoxib |
ChEMBL ID
|
CHEMBL122 |
Indication
|
dysmenorrhea, osteoarthritis |
Drug Class
|
Cyclooxygenase-2 inhibitors |
Image (chem structure or protein)